Avoiding pitfalls in the pursuit of a COVID-19 vaccine

Positive RT-PCR test results in patients recovered from COVID-19

Lan, L., Xu, D., Ye, G., Xia, C., Wang, S., Li, Y., & Xu, H. (2020) · JAMA · doi:10.1001/jama.2020.2783 · Cited by 1,251 · see citing works

A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge

Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477 · see citing works

Antibody-Dependent Enhancement of Virus Infection and Disease

Cancel-Tirado, S. M., & Yoon, K. J. (2003) · Viral Immunology · doi:10.1089/088282403763635465 · Cited by 316 · see citing works

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

Vennema, H., de Groot, R. J., Harbour, D. A., Dalderup, M. J. M., Gruffydd-Jones, T., Horzinek, M. C., & Spaan, W. J. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1407-1409.1990 · Cited by 276 · see citing works

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Acosta, P. L., Caballero, M. T., & Polack, F. P. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00609-15 · Cited by 254 · see citing works

Immune Enhancement of Viral Infection

Halstead, S. B. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000406537 · Cited by 210 · see citing works

Medical Countermeasures Analysis of 2019-nCoV and Vaccine Risks for Antibody-Dependent Enhancement (ADE)Preprint

Ricke, D. O., & Malone, R. W. (2020) · SSRN Electronic Journal · doi:10.20944/preprints202003.0138.v1 · Cited by 48 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

Adaptive immunity to SARS-CoV-2 and COVID-19

Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works

Estimating the burden of SARS-CoV-2 in France

Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., et al. (2020) · Science · doi:10.1126/science.abc3517 · Cited by 1,038 · see citing works

Immune response, inflammation, and the clinical spectrum of COVID-19

García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739 · see citing works

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706 · see citing works

COVID-19 vaccine development and a potential nanomaterial path forward

Shin, M. D., Shukla, S., Chung, Y. H., Beiss, V., Chan, S. K., Ortega-Rivera, O. A., Wirth, D. M., Chen, A., Sack, M., Pokorski, J. K., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0737-y · Cited by 652 · see citing works

Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past

Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01949 · Cited by 471 · see citing works

Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)

Călina, D. C., Docea, A. O., Petrakis, D., Egorov, A. M., Ishmukhametov, A. A., Gabibov, A., Штильман, М. И., Kostoff, R. N., Carvalho, F. D., Vinceti, M., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4596 · Cited by 319 · see citing works

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

de Assis, R. R., Jain, A., Nakajima, R., Jasinskas, A., Felgner, J. H., Obiero, J. M., Norris, P. J., Stone, M., Simmons, G., Bagri, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20095-2 · Cited by 201 · see citing works

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target

Xia, B., Shen, X.-R., He, Y., Pan, X., Liu, F., Wang, Y., Yang, F., Fang, S., Wu, Y. L., Duan, Z., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00519-4 · Cited by 189 · see citing works

T Cell Responses to SARS-CoV-2

Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 181 · see citing works

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19

Huang, J., Song, W., Huang, H., & Sun, Q. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041131 · Cited by 161 · see citing works

COVID-19 Pandemic: an Overview of epidemiology, pathogenesis, Diagnostics and Potential Vaccines and Therapeutics

Amawi, H. A., Deiab, G. A., Aljabali, A. A. A., Dua, K., & Tambuwala, M. M. (2020) · Therapeutic Delivery · doi:10.4155/tde-2020-0035 · Cited by 155 · see citing works

Taking the pulse of COVID-19: a spatiotemporal perspective

Yang, C. P., Sha, D., Liu, Q., Li, Y., Lan, H., Guan, W. W., Hu, T., Li, Z., Zhang, Z., Thompson, J. H., et al. (2020) · International Journal of Digital Earth · doi:10.1080/17538947.2020.1809723 · Cited by 114 · see citing works

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19

Sempowski, G. D., Saunders, K. O., Acharya, P., Wiehe, K. J., & Haynes, B. F. (2020) · Cell · doi:10.1016/j.cell.2020.05.041 · Cited by 100 · see citing works

Nanocarrier vaccines for SARS-CoV-2

Machhi, J., Shahjin, F., Das, S., Patel, M., Abdelmoaty, M. M., Cohen, J. D., Singh, P., Baldi, A., Bajwa, N., Kumar, R., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.002 · Cited by 80 · see citing works

COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

DiPiazza, A. T., Leist, S. R., Abiona, O. M., Moliva, J. I., Werner, A. P., Minai, M., Nagata, B. M., Bock, K. W., Phung, E., Schäfer, A., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.018 · Cited by 89 · see citing works

COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development

Singh, R., Kang, A., Luo, X., Jeyanathan, M., Gillgrass, A. E., Afkhami, S., & Xing, Z. (2021) · The FASEB Journal · doi:10.1096/fj.202002662r · Cited by 95 · see citing works

COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation!

Khuroo, M. S., Khuroo, M. S., Khuroo, M. S., Sofi, A. A., & Khuroo, N. S. (2020) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2020.06.003 · Cited by 92 · see citing works

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19

Karthik, K., Senthilkumar, T. M. A., Udhayavel, S., & Raj, G. D. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1796425 · Cited by 87 · see citing works

COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds

Moore, J. P., & Klasse, P. J. (2020) · Journal of Virology · doi:10.1128/jvi.01083-20 · Cited by 86 · see citing works

Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design

Rice, A. M., Castillo-Morales, A., Ho, A. T., Mordstein, C., Mühlhausen, S., Watson, S. F., Cano, L., Young, B., Kudla, G. R., & Hurst, L. D. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa188 · Cited by 82 · see citing works

Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization

Klasse, P. J., & Moore, J. P. (2020) · eLife · doi:10.7554/elife.57877 · Cited by 78 · see citing works

Current Status of COVID‐19 (Pre)Clinical Vaccine Development

Ye, T., Zhong, Z., García‐Sastre, A., Schotsaert, M., & Geest, B. G. D. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008319 · Cited by 73 · see citing works

Nanomaterial Based Biosensors for Detection of Viruses Including SARS-CoV-2: A Review

Bisht, A., Mishra, A., Bisht, H. S., & Tripathi, R. M. (2021) · Journal of Analysis and Testing · doi:10.1007/s41664-021-00200-0 · Cited by 49 · see citing works

Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development

Călina, D. C., Sarkar, C. K., Arsene, A. L., Salehi, B., Docea, A. O., Mondal, M., Islam, M. T., Zali, A., & Sharifi‐Rad, J. (2020) · Immunologic Research · doi:10.1007/s12026-020-09154-4 · Cited by 70 · see citing works

Advancements in protein nanoparticle vaccine platforms to combat infectious disease

Butkovich, N., Li, E., Ramirez, A., Burkhardt, A. M., & Wang, S. (2020) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1681 · Cited by 70 · see citing works

Exploring lectin–glycan interactions to combat COVID-19: Lessons acquired from other enveloped viruses

da Silva, L. C. N., Mendonça, J. S. P., de Oliveira, W. F., Batista, K. L. R., Zagmignan, A., Viana, I. F. T., & Correia, M. T. D. S. (2020) · Glycobiology · doi:10.1093/glycob/cwaa099 · Cited by 65 · see citing works

A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2

Wang, M., Fu, T., Hao, J., Li, L., Tian, M., Jin, N., Ren, L., & Li, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.239 · Cited by 61 · see citing works

Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development

Zhu, Y.-F., Li, J., & Pang, Z. (2020) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.06.001 · Cited by 52 · see citing works

Microarray patches enable the development of skin-targeted vaccines against COVID-19

Korkmaz, E., Balmert, S. C., Sumpter, T. L., Carey, C. D., Erdös, G., & Falo, L. D. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.022 · Cited by 59 · see citing works

Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals

Mahajan, S., Kode, V., Bhojak, K., Coral, K., Lee, K. M., Manoharan, M., Ramesh, A., Sudheendra, H., Srivastava, A., Sathian, R., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92521-4 · Cited by 54 · see citing works

Pressure Injury Prevention in COVID-19 Patients With Acute Respiratory Distress Syndrome

Victoria Team, Lydia Team, Jones, A., Teede, H. J., & Weller, C. D. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.558696 · Cited by 53 · see citing works

A lymph node–targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2

Steinbuck, M. P., Seenappa, L. M., Jakubowski, A., McNeil, L. K., Haqq, C. M., & DeMuth, P. C. (2021) · Science Advances · doi:10.1126/sciadv.abe5819 · Cited by 49 · see citing works

Vaccine Hesitancy and Effects of COVID-19

Erkekoğlu, P., KÖSE, S. B. E., Balcı, A., & Yirün, A. (2020) · Journal of Literature Pharmacy Sciences · doi:10.5336/pharmsci.2020-76102 · Cited by 51 · see citing works

Knowledge, preventive behavior and risk perception regarding COVID-19: a self-reported study on college students

Elhadi, M., Msherghi, A. A. A., Alsoufi, A., Buzreg, A., Bouhuwaish, A. E. M., Khaled, A., Alhadi, A., Alameen, H., Biala, M. I., Elgherwi, A., et al. (2020) · Pan African Medical Journal · doi:10.11604/pamj.supp.2020.35.2.23586 · Cited by 46 · see citing works

An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity

Fluckiger, A.-C., Ontsouka, B., Bozic, J., Diress, A., Ahmed, T., Berthoud, T. K., Tran, A., Duque, D., Liao, M., McCluskie, M. J., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.07.034 · Cited by 43 · see citing works

Enhancing Robustness and Resilience of Multiplex Networks Against Node-Community Cascading Failures

Ma, L., Zhang, X., Li, J., Lin, Q., Gong, M., Coello, C. A. C., & Nandi, A. K. (2021) · IEEE Transactions on Systems Man and Cybernetics Systems · doi:10.1109/tsmc.2021.3073212 · Cited by 42 · see citing works

Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies

Kahn, R. J., Kennedy‐Shaffer, L., Grad, Y. H., Robins, J. M., & Lipsitch, M. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa188 · Cited by 39 · see citing works

Drug repurposing approach to combating coronavirus: Potential drugs and drug targets

Xu, J., Xue, Y., Zhou, R., Shi, P., Li, H., & Zhou, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21763 · Cited by 39 · see citing works

Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics

Kabra, R., & Singh, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165978 · Cited by 38 · see citing works

BCG vaccination induced protection from COVID-19

Mohapatra, P. R., Mishra, B., & Behera, B. (2020) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2020.08.004 · Cited by 37 · see citing works

COVID‐19: Emergence of Infectious Diseases, Nanotechnology Aspects, Challenges, and Future Perspectives

Gupta, A., Kumar, S., Kumar, R., Choudhary, A. K., Kumari, K., Singh, P., & Kumar, V. (2020) · ChemistrySelect · doi:10.1002/slct.202001709 · Cited by 35 · see citing works

ANTIVIRAL EFFECTS OF BACTERIOCIN AGAINST ANIMAL-TO-HUMAN TRANSMITTABLE MUTATED SARS-COV-2: A SYSTEMATIC REVIEW

Dey, D., Ema, T. I., Biswas, P., Aktar, S., ISLAM, S., Rinik, U. R., Firoz, M., Ahmed, S. Z., Azad, S. A., Rahman, A., et al. (2021) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2021397 · Cited by 30 · see citing works

The Nigerian Pharmaceutical Supply Chain: Blockchain Adoption, Counterfeit Drugs and Successful Deployment of COVID-19 Vaccine in Nigeria

Labaran, M. J., & Hamma-Adama, M. (2021) · Journal of Scientific Research and Reports · doi:10.9734/jsrr/2021/v27i230356 · Cited by 28 · see citing works

Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic

Chakraborty, C., Sharma, A. R., Bhattacharya, M., Sharma, G., Saha, R. P., & Lee, S. (2021) · Immune Network · doi:10.4110/in.2021.21.e5 · Cited by 25 · see citing works

Strategies for Immunomonitoring after Vaccination and during Infection

Adam, L., Rosenbaum, P., Bonduelle, O., & Combadière, B. (2021) · Vaccines · doi:10.3390/vaccines9040365 · Cited by 24 · see citing works

“Tomorrow Never Dies”: Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies

Laskar, P., Yallapu, M. M., & Chauhan, S. C. (2020) · Diseases · doi:10.3390/diseases8030030 · Cited by 25 · see citing works

Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers

Jackson-Thompson, B. M., Goguet, E., Laing, E. D., Olsen, C. H., Pollett, S. D., Hollis-Perry, M., Maiolatesi, S. E., Illinik, L., Ramsey, K. F., Reyes, A. E., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06233-1 · Cited by 23 · see citing works

COVID-19: respuesta inmune y perspectivas terapéuticas

Lozada-Requena, I., & Ponce, C. (2020) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2020.372.5490 · Cited by 22 · see citing works

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death

Székely, L., Bozóky, B., Béndek, M., Ostad, M., Lavignasse, P., Haag, L., Wu, J., Xu, J., Gupta, S., Saccon, E., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07134 · Cited by 21 · see citing works

Generation of SARS-CoV‑2 S1 Spike Glycoprotein Putative Antigenic Epitopes in Vitro by Intracellular Aminopeptidases

Stamatakis, G. M., Samiotaki, M. K., Mpakali, A., Panayotou, G., & Stratikos, E. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00457 · Cited by 21 · see citing works

Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review

Zielińska, A., Eder, P., Karczewski, J., Szalata, M., Hryhorowicz, S., Wielgus, K., Szalata, M., Dobrowolska, A., Atanasov, A. G., Słomski, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147991 · Cited by 21 · see citing works

Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19

Coish, J. M., & MacNeil, A. J. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.06.006 · Cited by 18 · see citing works

Developing a reciprocating mechanism for the emergency implementation of a Mechanical Pulmonary Ventilator using an integrated CAD-MBD procedure

Pappalardo, C., Vece, A., Galdi, D., & Guida, D. (2022) · FME Transaction · doi:10.5937/fme2201238p · Cited by 18 · see citing works

Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2

Purbey, P. K., Roy, K., Gupta, S., & Paul, M. K. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.03.009 · Cited by 18 · see citing works

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccinePreprint

Gauttier, V., Morello, A., Girault, I., Mary, C., Belarif, L., Desselle, A., Wilhelm, E., Bourquard, T., Pengam, S., Teppaz, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.14.240093 · Cited by 17 · see citing works

Characterizing clinical progression of COVID-19 among patients in Shenzhen, China: an observational cohort studyPreprint

Bi, Q., Hong, C., Meng, J., Wu, Z., Zhou, P., Ye, C., Sun, B., Kucirka, L. M., Azman, A. S., Wang, T., et al. (2020) · medRxiv · doi:10.1101/2020.04.22.20076190 · Cited by 16 · see citing works

Research ethics and public trust in vaccines: the case of COVID-19 challenge trials

Eyal, N. (2022) · Journal of Medical Ethics · doi:10.1136/medethics-2021-108086 · Cited by 15 · see citing works

Immunology and Population Health: Collaboration without Convergence

Fagan, M. B. (2023) · Philosophy of Science · doi:10.1017/psa.2023.21 · Cited by 15 · see citing works

Nanomedicinal Delivery of Stimulator Of Interferon Genes Agonists: Recent Advances in Virus Vaccination

Chattopadhyay, S., & Hu, C. J. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0269 · Cited by 15 · see citing works

Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Dan, J. M., Antunes, R. D. S., Grifoni, A., Weiskopf, D., Crotty, S., & Sette, A. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac310 · Cited by 16 · see citing works

Potential of live pathogen vaccines for defeating the COVID‐19 pandemic: History and mechanism

Chen, J., & Chen, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25920 · Cited by 14 · see citing works

The perplexing question of trained immunity vs adaptive memory in COVID‐19

Kerboua, K. E. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26083 · Cited by 14 · see citing works

BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?

Kamat, S., & Kumari, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01050 · Cited by 14 · see citing works

Immunité adaptative contre le virus SARS-CoV-2

Combadière, B. (2020) · médecine/sciences · doi:10.1051/medsci/2020168 · Cited by 14 · see citing works

Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses

Dawson, E. D., Kuck, L. R., Blair, R. H., Taylor, A. W., Toth, E., Knight, V., & Rowlen, K. L. (2021) · Journal of Virological Methods · doi:10.1016/j.jviromet.2021.114111 · Cited by 14 · see citing works

COVID‐19 vaccines and nanomedicine

Shapiro, R. S. (2021) · International Journal of Dermatology · doi:10.1111/ijd.15673 · Cited by 14 · see citing works

The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2

Morris, K. V. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.06.005 · Cited by 14 · see citing works

COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus

Tavakol, S., Alavijeh, M. S., & Seifalian, A. M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201023143956 · Cited by 13 · see citing works

Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?

Helle, K. B., Sadiku, A., Zelleke, G. M., Bouba, A., Ibrahim, T. B., Obama, H. C. J. T., Appiah, V., Ngwa, G. A., Teboh-Ewungkem, M. I., & Schneider, K. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253758 · Cited by 13 · see citing works

COVID-19 Therapeutics for Low- and Middle-Income Countries: A Review of Candidate Agents with Potential for Near-Term Use and Impact

Maxwell, D. N., Sanders, K. C., Sabot, O. J., Hachem, A. A., Llanos‐Cuentas, A., Olotu, A., Gosling, R. D., Cutrell, J. B., & Hsiang, M. S. (2021) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0200 · Cited by 13 · see citing works

Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms

Bayat, M., Asemani, Y., & Najafi, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107679 · Cited by 14 · see citing works

A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2

Sarkar, A., Paul, S., Singh, C., Chowdhury, N., Nag, P., Das, S., Kumar, S., Sharma, A., Das, D. K., Dutta, D., et al. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198768 · Cited by 12 · see citing works

The Potential Role of Super Spread Events in SARS-COV-2 Pandemic; a Narrative Review.

Kyriakopoulos, A. M., Papaefthymiou, A., Georgilas, N., Doulberis, M., & Kountouras, J. (2020) · Archives of Academic Emergency Medicine · Cited by 12 · see citing works

COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review

Naz, S., Zahoor, M., Sahibzada, M. U. K., Ullah, R., & Alqahtani, A. S. (2021) · Open Chemistry · doi:10.1515/chem-2021-0049 · Cited by 11 · see citing works

Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs

Maurya, R., Shamim, U., Mishra, P., Swaminathan, A., Raina, A., Tarai, B., Budhiraja, S., & Pandey, R. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04292-22 · Cited by 11 · see citing works

Engineered human mesenchymal stem cells as new vaccine platform for COVID-19Preprint

Liu, J., Jiao, H., & Yin, X. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.20.163030 · Cited by 11 · see citing works

Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment

White, I. A., Tamot, N., Doddareddy, R., Ho, J., Jiao, Q., Harvilla, P. B., Yang, T., Geist, B. J., Borrok, M. J., Truppo, M. D., et al. (2021) · mAbs · doi:10.1080/19420862.2021.1987180 · Cited by 10 · see citing works

Topics in Antivax and Provax Discourse: Yearlong Synoptic Study of COVID-19 Vaccine Tweets

Zaidi, Z., Ye, M., Samon, F., Jama, A., Gopalakrishnan, B., Gu, C., Karunasekera, S. A., Evans, J., & Kashima, Y. (2023) · Journal of Medical Internet Research · doi:10.2196/45069 · Cited by 10 · see citing works

The role of the urologist, BCG vaccine administration, and SARS‐CoV‐2: An overview

Brooks, N. A., Narayan, V. M., Hegarty, P. K., Zafirakis, H., Han, X., & Kamat, A. M. (2020) · BJUI Compass · doi:10.1002/bco2.21 · Cited by 10 · see citing works

Vaccine-enhanced disease: case studies and ethical implications for research and public health

Jamrozik, E., Heriot, G., Bull, S., Parker, M. J., & (GLIDE), O.-J. H. G. I. D. E. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16849.1 · Cited by 10 · see citing works

Determinants and Willingness to Pay for Purchasing Mask against COVID-19: A Protection Motivation Theory Perspective

Ding, Q., Lin, S., & Wang, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074268 · Cited by 10 · see citing works

COVID-19 in Light of Seasonal Respiratory Infections

Kiseleva, I., Grigorieva, E., Larionova, N. V., Farroukh, M. A., & Георгиевна, Р. Л. (2020) · Biology · doi:10.3390/biology9090240 · Cited by 10 · see citing works

Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies

Steuwer, B., Jamrozik, E., & Eyal, N. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.02.038 · Cited by 9 · see citing works

An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2

Xie, T., He, Z., Liang, C., Dong, H.-N., Zhou, J., Fan, S.-J., & Guo, X. (2021) · European journal of medical research · doi:10.1186/s40001-021-00609-4 · Cited by 9 · see citing works

A review of COVID‐19 vaccines and major considerations for diabetic patients

Soltani, S., Zandi, M., Aghbash, P. S., Rezaei, M., Mohammadzadeh, N., Afsharifar, A., & Poortahmasebi, V. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2076 · Cited by 8 · see citing works

Attitude and Acceptance towards COVID-19 Booster Doses among Literacy Advantaged Population in Pakistan: A Cross-Sectional Study

Ahmad, M., Sattar, A., Aroosa, S., Majeed, A., Rasheed, M. A., Ahmad, W., Iqbal, A., Omer, M. O., Beg, B. M., & Mushtaq, R. M. Z. (2023) · Vaccines · doi:10.3390/vaccines11071238 · Cited by 8 · see citing works

PNAS and the pandemic

Berenbaum, M. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006488117 · Cited by 8 · see citing works

Phytochemicals as Potential Curative Agents against Viral Infection: A Review

Kumar, A., Singh, A. K., & Tripathi, G. (2020) · Current Organic Chemistry · doi:10.2174/138527282499920091009352 · Cited by 7 · see citing works

Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19

Poteryaev, D. A., Авгатович, Х. Р., Efimov, G. A., & Shuster, А. М. (2020) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2020-20-3-146-158 · Cited by 7 · see citing works

Profile of SARS-CoV-2

Heinz, F. X., & Stiasny, K. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01763-1 · Cited by 7 · see citing works

An Account of Immune Senescence in the Clinical Pathophysiology of COVID-19 Infection in Aging

Jain, S., Abrham, E., Khan, M., & Mathur, R. (2021) · Aging and Disease · doi:10.14336/ad.2020.1019 · Cited by 7 · see citing works

SARS-CoV-2-induced host metabolic reprogram (HMR): nutritional interventions for global management of COVID-19 and post-acute sequelae of COVID-19 (PASC)

Naidu, A. S., Shahidi, F., Wang, C., Sato, K., Wirakartakusumah, A., Aworh, O. C., & Clemens, R. (2022) · Journal of Food Bioactives · doi:10.31665/jfb.2022.18306 · Cited by 7 · see citing works

Comparative seasonalities of influenza A, B and ‘common cold’ coronaviruses – setting the scene for SARS-CoV-2 infections and possible unexpected host immune interactions

Liu, Y., Lam, T. T., Lai, F. Y. L., Krajden, M., Drews, S. J., Hatchette, T. F., Fraaij, P. L. A., van Kampen, J. J. A., Badarch, D., Nymadawa, P., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.032 · Cited by 7 · see citing works

Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests

Eyal, N., Gerhard, T., & Strom, B. L. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.04.056 · Cited by 6 · see citing works

Pandemic number five – Latest insights into the COVID-19 crisis

Häfner, S. J. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.08.008 · Cited by 6 · see citing works

Current Status of COVID‐19 (Pre)Clinical Vaccine Development

Ye, T., Zhong, Z., García‐Sastre, A., Schotsaert, M., & Geest, B. G. D. (2020) · Angewandte Chemie · doi:10.1002/ange.202008319 · Cited by 6 · see citing works

Leveraging Nanotechnology for Addressing COVID-19: Revealing Antiviral Approaches and Hurdles

Mostafavi, M., & Shabani, M. (2024) · World Journal of Nano Science and Engineering · doi:10.4236/wjnse.2024.141001 · Cited by 5 · see citing works

Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges

Abdullahi, I. N., Emeribe, A. U., Adekola, H. A., Abubakar, S. D., Dangana, A., Shuwa, H. A., Nwoba, S. T., Mustapha, J. O., Haruna, M., Olowookere, A. K., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1812313 · Cited by 5 · see citing works

COVID-19 vaccine design: the Janus face of immune enhancement

Hotez, P. J., Corry, D. B., & Bottazzi, M. E. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0323-4 · Cited by 168 · see citing works

Prospects for a safe COVID-19 vaccine

Haynes, B. F., Corey, L., Fernandes, P., Gilbert, P. B., Hotez, P. J., Rao, S., Santos, M. R., Schuitemaker, H., Watson, M., & Arvin, A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abe0948 · Cited by 261 · see citing works

Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development

de Alwis, R., Chen, S., Gan, E. S., & Ooi, E. E. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102768 · Cited by 132 · see citing works

Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety

Kostoff, R. N., Kanduc, D., Porter, A. L., Shoenfeld, Y., Călina, D. C., Briggs, M. B., Spandidos, D. A., & Tsatsakis, A. M. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.10.016 · Cited by 61 · see citing works

Coronavirus vaccine developers wary of errant antibodies

Garber, K. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00016-w · Cited by 11 · see citing works